280 related articles for article (PubMed ID: 34516550)
1. Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain.
Suzzi S; Ahrendt R; Hans S; Semenova SA; Chekuru A; Wirsching P; Kroehne V; Bilican S; Sayed S; Winkler S; Spieß S; Machate A; Kaslin J; Panula P; Brand M
PLoS Genet; 2021 Sep; 17(9):e1009794. PubMed ID: 34516550
[TBL] [Abstract][Full Text] [Related]
2. LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation.
Prabhudesai S; Bensabeur FZ; Abdullah R; Basak I; Baez S; Alves G; Holtzman NG; Larsen JP; Møller SG
J Neurosci Res; 2016 Aug; 94(8):717-35. PubMed ID: 27265751
[TBL] [Abstract][Full Text] [Related]
3. Disruption of LRRK2 does not cause specific loss of dopaminergic neurons in zebrafish.
Ren G; Xin S; Li S; Zhong H; Lin S
PLoS One; 2011; 6(6):e20630. PubMed ID: 21698186
[TBL] [Abstract][Full Text] [Related]
4. Disruption of LRRK2 in Zebrafish leads to hyperactivity and weakened antibacterial response.
Sheng D; See K; Hu X; Yu D; Wang Y; Liu Q; Li F; Lu M; Zhao J; Liu J
Biochem Biophys Res Commun; 2018 Mar; 497(4):1104-1109. PubMed ID: 29499195
[TBL] [Abstract][Full Text] [Related]
5. Lrrk2 modulation of Wnt signaling during zebrafish development.
Wint JM; Sirotkin HI
J Neurosci Res; 2020 Oct; 98(10):1831-1842. PubMed ID: 32623786
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect.
Sheng D; Qu D; Kwok KH; Ng SS; Lim AY; Aw SS; Lee CW; Sung WK; Tan EK; Lufkin T; Jesuthasan S; Sinnakaruppan M; Liu J
PLoS Genet; 2010 Apr; 6(4):e1000914. PubMed ID: 20421934
[TBL] [Abstract][Full Text] [Related]
7. LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT
Lim J; Bang Y; Choi JH; Han A; Kwon MS; Liu KH; Choi HJ
J Neurosci; 2018 Feb; 38(7):1611-1621. PubMed ID: 29305532
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.
Higashi S; Moore DJ; Colebrooke RE; Biskup S; Dawson VL; Arai H; Dawson TM; Emson PC
J Neurochem; 2007 Jan; 100(2):368-81. PubMed ID: 17101029
[TBL] [Abstract][Full Text] [Related]
9. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease.
Westerlund M; Belin AC; Anvret A; Bickford P; Olson L; Galter D
Neuroscience; 2008 Mar; 152(2):429-36. PubMed ID: 18272292
[TBL] [Abstract][Full Text] [Related]
10. Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond.
Göring S; Taymans JM; Baekelandt V; Schmidt B
Bioorg Med Chem Lett; 2014 Oct; 24(19):4630-4637. PubMed ID: 25219901
[TBL] [Abstract][Full Text] [Related]
11. Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a Drosophila model of Parkinson's disease.
Islam MS; Nolte H; Jacob W; Ziegler AB; Pütz S; Grosjean Y; Szczepanowska K; Trifunovic A; Braun T; Heumann H; Heumann R; Hovemann B; Moore DJ; Krüger M
Hum Mol Genet; 2016 Dec; 25(24):5365-5382. PubMed ID: 27794539
[TBL] [Abstract][Full Text] [Related]
12. Abnormal brain development of monoamine oxidase mutant zebrafish and impaired social interaction of heterozygous fish.
Baronio D; Chen YC; Panula P
Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 34881779
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
14. Mutant G2019S-LRRK2 Induces Abnormalities in Arteriolar Cerebral Blood Volume in Mouse Brains: An MRI Study.
Ning B; Guo G; Gu C; Xu J; Bibic A; He X; Liu H; Chen L; Wei Z; Duan W; Liu P; Lu H; van Zijl PCM; Ross CA; Smith W; Hua J
Neurodegener Dis; 2020; 20(2-3):65-72. PubMed ID: 33152738
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA).
Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL
Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487
[TBL] [Abstract][Full Text] [Related]
16. The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
Giesert F; Glasl L; Zimprich A; Ernst L; Piccoli G; Stautner C; Zerle J; Hölter SM; Vogt Weisenhorn DM; Wurst W
Neurobiol Dis; 2017 Sep; 105():179-193. PubMed ID: 28576705
[TBL] [Abstract][Full Text] [Related]
17. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.
Giesert F; Hofmann A; Bürger A; Zerle J; Kloos K; Hafen U; Ernst L; Zhang J; Vogt-Weisenhorn DM; Wurst W
PLoS One; 2013; 8(5):e63778. PubMed ID: 23675505
[TBL] [Abstract][Full Text] [Related]
19. Models of LRRK2-Associated Parkinson's Disease.
Xiong Y; Dawson TM; Dawson VL
Adv Neurobiol; 2017; 14():163-191. PubMed ID: 28353284
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Nguyen APT; Tsika E; Kelly K; Levine N; Chen X; West AB; Boularand S; Barneoud P; Moore DJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17296-17307. PubMed ID: 32631998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
